Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report

被引：1770
作者：
Malfertheiner, Peter [1 ]
Megraud, Francis [2 ]
O'Morain, Colm A. [3 ]
Atherton, John [4 ]
Axon, Anthony T. R. [5 ]
Bazzoli, Franco [6 ]
Gensini, Gian Franco [8 ]
Gisbert, Javier P. [9 ]
Graham, David Y. [10 ]
Rokkas, Theodore [11 ]
El-Omar, Emad M. [7 ]
Kuipers, Ernst J. [12 ]
机构：
[1] Univ Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany
[2] Univ Bordeaux 2, Dept Bacteriol, INSERM, U853, F-33076 Bordeaux, France
[3] Trinity Coll Dublin, Adelaide & Meath Hosp, Dept Gastroenterol, Dublin, Ireland
[4] Univ Nottingham, Sch Clin Sci, Nottingham, England
[5] Spire Leeds Hosp, Leeds, W Yorkshire, England
[6] Univ Bologna, Bologna, Italy
[7] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland
[8] Univ Florence, Florence, Italy
[9] Hosp Univ Princesa, IP & CIBEREHD, Madrid, Spain
[10] VA Med Ctr Houston, Houston, TX USA
[11] Henry Dunant Hosp, Dept Gastroenterol, Athens, Greece
[12] Erasmus MC Univ Med Ctr, Rotterdam, Netherlands
来源：
GUT | 2012年 / 61卷 / 05期
关键词：
PROTON-PUMP INHIBITOR; DIFFUSE GASTRIC-CANCER; C-13-UREA BREATH TEST; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACID-SUPPRESSIVE THERAPY; PEPTIC-ULCER DISEASE; STOOL ANTIGEN TEST; TERM-FOLLOW-UP; EARLY REBLEEDING RATE; N-NITROSO COMPOUNDS;
D O I：
10.1136/gutjnl-2012-302084
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.
引用
收藏
页码：646 / 664
页数：19
相关论文
共 329 条
  • [1] The Eradication of Helicobacter pylori is Affected by Body Mass Index (BMI)
    Abdullahi, Mohamed
    Annibale, Bruno
    Capoccia, Danila
    Tari, Roberto
    Lahner, Edith
    Osborn, John
    Leonetti, Frida
    Severi, Carola
    [J]. OBESITY SURGERY, 2008, 18 (11) : 1450 - 1454
  • [2] Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis
    Acosta, Nicole
    Quiroga, Andres
    Delgado, Pilar
    Mercedes Bravo, Maria
    Jaramillo, Carlos
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (31) : 3936 - 3943
  • [3] Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines
    Aebischer, T.
    Bumann, D.
    Epple, H. J.
    Metzger, W.
    Schneider, T.
    Cherepnev, G.
    Walduck, A. K.
    Kunkel, D.
    Moos, V.
    Loddenkemper, C.
    Jiadze, I.
    Panasyuk, M.
    Stolte, M.
    Graham, D. Y.
    Zeitz, M.
    Meyer, T. F.
    [J]. GUT, 2008, 57 (08) : 1065 - 1072
  • [4] Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries
    Agudo, A
    Slimani, N
    Ocké, MC
    Naska, A
    Miller, AB
    Kroke, A
    Bamia, C
    Karalis, D
    Vineis, P
    Palli, D
    Bueno-de-Mesquita, HB
    Peeters, PHM
    Engeset, D
    Hjartåker, A
    Navarro, C
    Garcia, CM
    Wallström, P
    Zhang, JX
    Welch, AA
    Spencer, E
    Stripp, C
    Overvad, K
    Clavel-Chapelon, F
    Casagrande, C
    Riboli, E
    [J]. PUBLIC HEALTH NUTRITION, 2002, 5 (6B) : 1179 - 1196
  • [5] High Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains and Risk Factors Associated with Resistance in Madrid, Spain
    Agudo, Sonia
    Perez-Perez, Guillermo
    Alarcon, Teresa
    Lopez-Brea, Manuel
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (10) : 3703 - 3707
  • [6] Host-bacterial interactions in Helicobacter pylori infection
    Amieva, Manuel R.
    El-Omar, Emad M.
    [J]. GASTROENTEROLOGY, 2008, 134 (01) : 306 - 323
  • [7] The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis
    Annibale, B
    Di Giulio, E
    Caruana, P
    Lahner, E
    Capurso, G
    Bordi, C
    Delle Fave, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1723 - 1731
  • [8] Helicobacter pylori eradication in the healing of atrophic gastritis:: A one-year prospective study
    Arkkila, PET
    Seppälä, K
    Färkkilä, MA
    Veijola, L
    Sipponen, P
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (07) : 782 - 790
  • [9] Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers
    Arkkila, PET
    Seppälä, K
    Kosunen, TU
    Sipponen, P
    Mäkinen, J
    Rautelin, H
    Färkkilä, M
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : 93 - 101
  • [10] Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review
    Arnold, Donald M.
    Bernotas, Ashley
    Nazi, Ishac
    Stasi, Roberto
    Kuwana, Masataka
    Liu, Yang
    Kelton, John G.
    Crowther, Mark A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (06): : 850 - 856
12345678910